Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence;Syndrome de sevrage au cannabis dans une population de patients mono- et polydépendants (cannabis et opiacés)

Encephale

Volumn 37, Issue 4, 2011, Pages 266-272

  Vorspan, F ^a   Guillem, E ^a,b   Bloch, V ^a,b   Bellais, L ^a,b   Sicot, R ^a   Noble, F ^b   Lepine, J P ^a,b   Gorelick, D A ^c  

^a HÔPITAL FERNAND WIDAL   (France)

^b INSERM   (France)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cannabis; Dependence; Opiates; Withdrawal

Indexed keywords

CANNABIS; OPIATE;

AGGRESSION; ANOREXIA; ANXIETY; ARTICLE; CANNABIS ADDICTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; HYPOTHESIS; IRRITABILITY; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; OPIATE ADDICTION; RESTLESSNESS; RETROSPECTIVE STUDY; SLEEP DISORDER; STRUCTURED INTERVIEW; SYMPTOM; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ADULT; CANNABINOIDS; COMORBIDITY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; REHABILITATION CENTERS; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 80053927080     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2010.12.007     Document Type: Article

References (38)

1. A. Agrawal, M.L. Pergadia, and M.T. Lynskey Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? Am J Addiction 17 2008 199 208 (Pubitemid 351883176)
2. S. Asfani-Farhang, P. Hatchuel, and L. Bourhis Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers Ann Med Interne (Paris) 152 suppl 3 2001 IS 37 IS 42
3. K. Bolla, S. Lesage, and C. Gamaldo Sleep disturbance in heavy marijuana users Sleep 31 2008 901 908 (Pubitemid 351810521)
4. A.J. Budney, R.G. Vandrey, and J.R. Hughes Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse J Subst Abuse Treat 35 4 2008 362 368
5. A.J. Budney, J.R. Hughes, and B.A. Moore Review of the validity and significance of cannabis withdrawal syndrome Am J Psychiatry 161 11 2004 1967 1977 (Pubitemid 39441395)
6. A.J. Budney, B.A. Moore, and R.G. Vandrey The time course and significance of cannabis withdrawal J Abnorm Psychol 112 3 2003 393 402 (Pubitemid 36959365)
7. A.J. Budney, P.L. Novy, and J.R. Hughes Marijuana withdrawal among adults seeking treatment for marijuana dependence Addiction 94 9 1999 1311 1322 (Pubitemid 29433790)
8. A.J. Budney, W.K. Bickel, and L. Amass Marijuana use and treatment outcome among opioid-dependent patients Addiction 93 4 1998 493 503 (Pubitemid 28188069)
9. C. Cadoni, A. Pisanu, and M. Solinas Behavioral sensitization fater repeated exposure to delta(9)-tetrahydrocannabinol and cross-sensitization with morphine Psychopharmacology (Berl) 158 3 2001 259 266 (Pubitemid 33071163)
10. T. Chung, C.S. Martin, and J.R. Cornelius Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents Addiction 103 5 2008 787 799 (Pubitemid 351537680)
11. M.L. Copersino, S.J. Boyd, and D.P. Tashlin Cannabis withdrawal among non-treatment-seeking adult cannabis users Am J Addiction 15 2006 8 14 (Pubitemid 43207184)
12. J.R. Cornelius, T. Chung, and C. Martin Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence Addict Behav 33 2008 1500 1505
13. S. Darke Self-report among injecting drug users: a review Drug Alcohol Depend 51 3 1998 253 263
14. E. Guillem, A. Pelissolo, and F. Vorspan Facteurs sociodé mographiques, conduites addictives et comorbidité psychiatrique des usagers de cannabis vus en consultation spécialisée L'Encéphale 35 3 2009 226 233
15. M. Haney, A.S. Ward, and S.D. Comer Abstinence symptoms following smoked marijuana in humans Psychopharmacology (Berl) 141 4 1999 395 404 (Pubitemid 29190008)
16. D.S. Hasin, K.M. Keyes, and D. Alderson Cannabis withdrawal in the United-States: results from NESARC J Clin Psychiatry 69 9 2008 1354 1363
17. F. Jardinaud, B.P. Roques, and F. Noble Tolerance to the reinforcing effects of morphine in delta(9)-tetrahydrocannabinol treated mice Behav Brain Res 173 2 2006 255 261 (Pubitemid 44291827)
18. R.T. Jones, N. Benowitz, and J. Bachman Clinical studies of cannabis tolerance and dependence Ann N Y Acad Sci 282 1976 221 239 (Pubitemid 8023834)
19. E.M. Kouri, and H.G. Pope Jr Abstinence symptoms during withdrawal from chronic marijuana use Exp Clin Psychopharmacol 8 4 2000 483 492
20. S. Lamarque, K. Taghzouti, and H. Simon Chronic treatment with delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction Neuropharmacology 41 1 2001 118 129 (Pubitemid 32607651)
21. E. Lavie, M. Fatseas, and C. Denis Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence Drug Alcohol Depend 99 2009 338 344
22. C. Manzanedo, M.A. Aguilar, and M. Rodriguez-Arias Cannabinoid agonistinduced sensitisation to morphine place preference in mice Neuroreport 15 8 2004 1373 1377 (Pubitemid 38757284)
23. M. Mas-Nieto, B. Pommier, and E.T. Tzavara Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction Br J Pharmacol 132 8 2001 1809 1816 (Pubitemid 32397973)
24. C.E. Mennes, A. Ben Abdallah, and B. Linda The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: multisite study of differences between general population and treatment groups Addict Behav 34 2009 223 236
25. L.J. Morel, B. Giros, and V. Daugé Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats Neuropsychopharmacology 34 11 2009 2469 2476
26. OAS. (Office of applied studies). Results from the 2008 national survey on drug use and health: National, findings. http://www.oas.samhsa.gov/NSDUH/ 2k8NSDUH/2K8results.cfm#3Ch2
27. OEDT. 2009 Rapport annuel sur l'usage de drogues en Europe. http://www.emcdda.europa.eu/publications/annual-report/2008
28. E Peles, S. Schreiber, and M. Adelson Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose Eur Neuropsychopharmacol 19 8 2009 581 588
29. C. Rios, I. Gomes, and L.A. Devi CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signalling and neuritogenesis Br J Pharmacol 148 4 2006 387 395 (Pubitemid 43882074)
30. J.J. Rodriguez, K. Mackie, and V.M. Pickel Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus J Neurosci 21 3 2001 823 833 (Pubitemid 32163123)
31. D.V. Sheehan, Y. Lecrubier, and K.H. Sheehan The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl 20 1998 22 33 (Pubitemid 29001829)
32. R.G. Vandrey, A.J. Budney, and J.R. Hughes A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances Drug Alcohol Depend 92 1-3 2008 48 54 (Pubitemid 350213236)
33. R. Vandrey, A.J. Budney, and J.L. Kamon Cannabis withdrawal in adolescent treatment seekers Drug Alcohol Depend 78 2 2005 205 210 (Pubitemid 40544608)
34. G. Vidal-Trecan, I. Varescon, and N. Nabet Intraveinous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France Drug Alcohol Depend 69 2003 175 181 (Pubitemid 36262027)
35. D. Vigano, T. Rubino, and A. Vaccani Molecular mechanisms involved in the asymetric interaction between cannabinoid and opioid systems Psychopharmacolgy (Berl) 182 4 2005 527 536 (Pubitemid 41464634)
36. F. Vorspan, E. Guillem, and V. Bloch Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence Sleep Med 11 5 2010 499 500
37. D. Wang, and H. Teichtahl Opioids, sleep architecture and sleep-disordered breathing Sleep Medicine Reviews 11 2007 35 46 (Pubitemid 46096783)
38. L. Yao, K. McFarland, and P. Fan Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behaviour in addicted rats PNAS 103 20 2006 7877 7882